[HTML][HTML] The use of erlotinib in daily practice: a study on adherence and patients' experiences

L Timmers, CCLM Boons, D Mangnus, JE Moes… - BMC cancer, 2011 - Springer
… of interventions that may increase adherence. This paper presents the CAPER-erlotinib
protocol, which is designed to study the relationship between adherence to erlotinib and both the …

[HTML][HTML] Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer

L Timmers, CCLM Boons, J Moes-Ten Hove… - Journal of cancer …, 2015 - Springer
… The median duration of treatment with erlotinib in the present studyuse of erlotinib from
the patients’ perspective. To our knowledge, adherence to erlotinib neither has been studied

Factors associated with adherence to and treatment duration of erlotinib among patients with non-small cell lung cancer

LM Hess, A Louder, K Winfree, YE Zhu, AB Oton… - Journal of managed …, 2017 - jmcp.org
… While adherence measures the use of a medication in … In the current study, adherence
was reported to be above 80… The reasons for high adherence in some of the studies may …

Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced Non–Small-Cell lung cancer

V Gebbia, M Bellavia, GL Banna, P Russo, F Ferraù… - Clinical lung cancer, 2013 - Elsevier
… with the use of the 2-sided log-rank test. Correlation analysis between … study may reflect in
part a trend to overestimate adherence by virtue of being enrolled in an adherence study or by …

Implementation of adherence to erlotinib by a treatment-monitoring program.

V Gebbia, M Bellavia, P Russo, GL Banna… - Journal of Clinical …, 2011 - ascopubs.org
adherence to second-line erlotinib in patients with advanced non-small cell lung cancer (A-NSCLC)
Methods: A retrospective non-interventional study … receive instructions or use a fast-…

Medication adherence and persistence among patients with non-small cell lung cancer receiving tyrosine kinase inhibitors and estimation of the economic burden …

R Joret, N Matti, M Beck… - Journal of Oncology …, 2022 - journals.sagepub.com
… , we can assume that the use of erlotinib in pancreatic cancer was marginal in our study. …
The adherence in this study was assessed using a medication event monitoring system and …

Multi-center observational study on the adherence, quality of life, and adverse events in lung cancer patients treated with tyrosine kinase inhibitors

J Rosentreter, J Alt, M Fried… - Journal of oncology …, 2021 - journals.sagepub.com
… It is noteworthy that in the present study not a single patient was treated with erlotinib, …
Previous studies on medication adherence in NSCLC patients were almost exclusively on erlotinib

[HTML][HTML] Adherence to targeted oral anticancer medications

DM Geynisman, KE Wickersham - Discovery medicine, 2013 - ncbi.nlm.nih.gov
… of patients with GIST have examined the role of toxicity on medication use and adherence.
In … levels of erlotinib. Findings from this study will provide information about adherence and …

Duration of treatment among patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive non-small-cell lung cancer in the USA

J Lim, C Samuelsen, A Golembesky, S Shrestha… - Future …, 2019 - Taylor & Francis
… and erlotinib, this study assessed time on treatment with these agents in the real-world setting.
The study … As both treatments evaluated in this study are only approved for use as first-line …

[PDF][PDF] Lung cancer: copayments and behavior following erlotinib formulary tier change

NM Engel-Nitz, S Satram-Hoang… - American Journal …, 2012 - ajpblive.s3.amazonaws.com
studies also affect adherence with erlotinib for patients with NSLC. The purpose of this
retrospective study … In our sensitivity analysis, erlotinib prescription use rates varied from 41% to 48…